Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BPC BioSed is an Italian diagnostics and laboratory equipment company that develops, manufactures, and markets automated biochemistry analyzers for clinical laboratories. Founded in 1986, the company evolved from a scientific instruments importer into an analyzer manufacturer, launching its first in-house system in 1991 and later expanding into multiple automated analyzer families. Its systems are used across clinical chemistry and related testing settings, with additional applications in veterinary, oenology, agri-food, and industrial analysis. BPC BioSed became part of the BIOLABO Group in 2016, and its analyzers are also commercialized under BIOLABO's KENZA brand. The company appears to operate as a commercial-stage diagnostics equipment manufacturer rather than a therapeutic biotech or drug-development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BPC BioSed.